Abstract
77 Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have